Literature DB >> 30858791

A case of papular elastorrhexis.

Meng Jiang1, Wenbo Bu1, Xu Chen1, Heng Gu1.   

Abstract

Entities:  

Year:  2019        PMID: 30858791      PMCID: PMC6409885          DOI: 10.5114/ada.2019.82832

Source DB:  PubMed          Journal:  Postepy Dermatol Alergol        ISSN: 1642-395X            Impact factor:   1.837


× No keyword cloud information.
An 11-year-old girl presented with a 2-year history of flesh-colored papules on her extremities (Figure 1). The lesions were asymptomatic, of oval or irregular shape and increased gradually both in size and numbers without any treatment. She denied a history of any other inflammatory dermatoses or trauma on the involved area. There was no family history of similar lesions. Dermatological examination showed that multiple flesh-colored, non-follicular papules were discrete and distributed over her lower limbs. The lesions were approximately 5–10 mm in diameter, of various shapes and slightly hard. No other primary or secondary lesions (erythema or scales, etc.) can be seen around the involved area. Histopathological examination of the skin lesion on the left thigh revealed hyperkeratosis, slight perivascular lymphocytes infiltration and a mild hyperplasia of collagen fiber in the dermis. Elastic tissue staining (Resorcinol-Fuchsin stain) showed a significant reduction, fragmentation or complete loss of elastic tissue in upper and mid dermis (Figure 2). Based on the clinical and histopathological features, a diagnosis of papular elastorrhexis was made. No treatment was performed because of the benign process of this disease and asymptomatic character of the lesions. She was followed up for one year and showed no improvement in the involved lesions.
Figure 1

Multiple flesh-colored non-follicular papules scattered on lower limbs

Figure 2

Histopathological examination showed hyperkeratosis, perivascular slight lymphocytes infiltration and a mild hyperplasia of collagen fiber in the dermis (H + E, A – 1.5×; B – 10×). Elastic tissue staining showed a significant reduction and fragmentation of elastic tissue in the dermis (Resorcinol-Fuchsin stain, C – 1.5×; D – 10×; E – 20×)

Multiple flesh-colored non-follicular papules scattered on lower limbs Histopathological examination showed hyperkeratosis, perivascular slight lymphocytes infiltration and a mild hyperplasia of collagen fiber in the dermis (H + E, A – 1.5×; B – 10×). Elastic tissue staining showed a significant reduction and fragmentation of elastic tissue in the dermis (Resorcinol-Fuchsin stain, C – 1.5×; D – 10×; E – 20×) Papular elastorrhexis (PE) is a rare acquired elastic tissue disorder which was first described by Bordas et al. [1] in 1987. The etiology of this disease is still unclear. Papular elastorrhexis usually occurs in children or adolescents with a predilection for women. Its clinical characteristics are multiple asymptomatic, non-follicular flesh-colored papules, between 3 and 5 mm in size. Papules are firm and mainly distributed over the trunk or upper extremities with no fusion. In addition, there is no osteopoikilosis or similar family history and usually occurs without any previous history of acne, inflammation or trauma. The prominent histopathological feature of PE is the reduction, fragmentation or complete loss of dermal elastic fibers. Collagen fibers can be normal, focally thickened or even homogenized with a few lymphocytes infiltrated around the blood vessels [2]. Papular elastorrhexis has not received a well-recognized division and it is still controversial whether PE is a distinct entity or a variant of nevus anelasticus (NA) or abortive form of Buschke-Ollendorff syndrome (BOS) [1, 3]. But it is generally confirmed that PE is a distinct entity different from other elastic tissue disorders including NA, BOS, eruptive collagenoma, white fibrous papulosis of the neck, pseudoxanthoma elasticum-like papillary dermal elastolysis (PXE-PDE), mid-dermal elastolysis and papular acne scars [4, 5]. These diseases clinically present with scattered white-to-yellow papules and show a reduction or loss of dermal elastic tissue in histology. Differential diagnosis of PE can be established with other elastic fiber disorders according to the different clinical features and primary histopathological changes. In our case, the onset age, the absence of osteopoikilosis, no family history or trauma history, clinical features of the papules, and the histopathological features of focal fragmentation and loss of elastic fibers are in accord with the character of PE. However, there is no recommended treatment for PE, including topical tretinoin, oral antibiotics or isotretinoin have been proved invalid. Notably, several cases show improvement after the intralesional injection of triamcinolone [4, 6]. In view of the benign process of PE, we suggest a long-term follow-up observation if possible.
  6 in total

1.  Papular elastorrhexis in childhood improved by intralesional injections of triamcinolone.

Authors:  S H Lee; S H Park; K Y Song; T J Yoon; T H Kim
Journal:  J Dermatol       Date:  2001-10       Impact factor: 4.005

Review 2.  Acquired disorders of elastic tissue: Part II. decreased elastic tissue.

Authors:  Kevan G Lewis; Lionel Bercovitch; Sara W Dill; Leslie Robinson-Bostom
Journal:  J Am Acad Dermatol       Date:  2004-08       Impact factor: 11.527

Review 3.  Papular elastorrhexis: report of four cases and review of literature.

Authors:  Di-Qing Luo; Juan-Hua Liu; Ming-Chun Chen; Zhuo Wang; Wen-Lin Xie
Journal:  Arch Dermatol Res       Date:  2014-10-11       Impact factor: 3.017

4.  Papular elastorrhexis: a variety of nevus anelasticus?

Authors:  X Bordas; C Ferrándiz; M Ribera; E Galofré
Journal:  Arch Dermatol       Date:  1987-04

Review 5.  Papular elastorrhexis: a variant of dermatofibrosis lenticularis disseminata (Buschke-Ollendorff syndrome)?

Authors:  H Schirren; C G Schirren; W Stolz; P Kind; G Plewig
Journal:  Dermatology       Date:  1994       Impact factor: 5.366

6.  Papular elastorrhexis. report of five cases.

Authors:  S A Buechner; P Itin
Journal:  Dermatology       Date:  2002       Impact factor: 5.366

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.